Iclusig

ASH: Takeda pads case for new leukemia use with 5-year survival data
ASH: Takeda pads case for new leukemia use with 5-year survival data
Fierce Pharma
Takeda
ASH2020
CML
Iclusig
Flag link:
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
Flag link:
Before Iclusig safety flaws went public, ex-Ariad staffer told family to sell shares: feds
Before Iclusig safety flaws went public, ex-Ariad staffer told family to sell shares: feds
Fierce Pharma
Iclusig
Ariad Pharma
insider trading
Flag link:
What Were Incyte’s Revenue Streams in 3Q16?
What Were Incyte’s Revenue Streams in 3Q16?
Market Realist
Incyte
Jakafi
Iclusig
Flag link:
Ariad's Iclusig Gets FDA OK and Label Update
Ariad's Iclusig Gets FDA OK and Label Update
Investopedia
Ariad Pharma
Iclusig
FDA
chronic myeloid leukemia
Ph+ ALL
Flag link:
Bernie Sanders Follows ‘Greed’ Tweet on Ariad With Letter
Bernie Sanders Follows ‘Greed’ Tweet on Ariad With Letter
Bloomberg
Bernie Sanders
twitter
Ariad Pharmaceuticals
Iclusig
drug pricing
Flag link:
Ariad sells off a share of Iclusig for a shot at $200M in R&D cash
Ariad sells off a share of Iclusig for a shot at $200M in R&D cash
Fierce Biotech
Ariad Pharmaceuticals
R&D
Iclusig
acute lymphoblastic leukemia
PDL Biopharma
Flag link:
Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?
Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?
Motley Fool
M&A
Ariad Pharmaceuticals
Eli Lilly
Iclusig
Jazz Pharmaceuticals
GSK
Flag link:
3 Ways Ariad Pharmaceuticals Can Salvage Iclusig
3 Ways Ariad Pharmaceuticals Can Salvage Iclusig
Motley Fool
Ariad Pharmaceuticals
Iclusig
acute lymphoblastic leukemia
Flag link:
Ariad Pharma Short Seller Explains Why Takeover Rumor is Bunk
Ariad Pharma Short Seller Explains Why Takeover Rumor is Bunk
TheStreet.com
Ariad Pharmaceuticals
M&A
AP26113
Eli Lilly
Iclusig
Flag link:
With Iclusig back to market, would Eli Lilly bid for Ariad? Would anyone?
With Iclusig back to market, would Eli Lilly bid for Ariad? Would anyone?
Fierce Pharma
Iclusig
M&A
Ariad Pharmaceuticals
Eli Lilly
Flag link:
4 Biggest Biotech Disasters Of 2013
4 Biggest Biotech Disasters Of 2013
Forbes
Amarin
Vascepa
Ariad Pharmaceuticals
Iclusig
Celsion
ThermoDox
IPI-145
Infinity Pharmaceuticals
Flag link:
Ariad Pharmaceuticals Catches Fire
Ariad Pharmaceuticals Catches Fire
TheStreet.com
Ariad Pharmaceuticals
Iclusig
FDA
Flag link:
Ariad says FDA OKs marketing of Iclusig after adding new safety warnings
Ariad says FDA OKs marketing of Iclusig after adding new safety warnings
Yahoo/AP
Ariad Pharmaceuticals
FDA
Iclusig
warnings
Flag link:
3 Drugmakers to Watch in the New Year
3 Drugmakers to Watch in the New Year
Motley Fool
pimavanserin
Acadia
Zerenex
Keryx
Iclusig
Ariad Pharmaceuticals
Flag link:
3 Biggest FDA Decisions of 2013
3 Biggest FDA Decisions of 2013
Motley Fool
FDA
Sarepta Therapeutics
drisapersen
Iclusig
Ariad Pharmaceuticals
Vascepa
Amarin
Flag link:
Ariad jumps as company says EU regulators may be willing to keep its cancer drug on the market
Ariad jumps as company says EU regulators may be willing to keep its cancer drug on the market
Yahoo/AP
Europe
Iclusig
Ariad Pharmaceuticals
Flag link:
2 Pharmas That Should Move After 55th ASH Meeting
2 Pharmas That Should Move After 55th ASH Meeting
Seeking Alpha
ASH
Iclusig
Ariad Pharmaceuticals
SL-401
CML
Stemline
Flag link:
5 FDA-Approved Drugs That Disappointed Investors in 2013
5 FDA-Approved Drugs That Disappointed Investors in 2013
Motley Fool
FDA
Amarin
Vivus
Dendreon
Arena Pharmaceuticals
Provenge
Vascepa
Iclusig
Ariad Pharmaceuticals
Belviq
Qsymia
Flag link:
Axe Falls on Ariad’s Workforce After Cancer Drug Blowup
Axe Falls on Ariad’s Workforce After Cancer Drug Blowup
Xconomy
Ariad Pharmaceuticals
layoffs
Iclusig
Flag link:

Pages